Old Web
English
Sign In
Acemap
>
authorDetail
>
G Radulescu
G Radulescu
Takeda Pharmaceutical Company
Physical therapy
Diabetes mellitus
Vedolizumab
Medicine
Internal medicine
3
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P621 Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn’s disease patients: results from the EVOLVE study
2019
Journal of Crohns & Colitis
Brian Bressler
G. Mantzaris
Mark S. Silverberg
P Zezos
D. Stein
C. Colby
Trevor Lissoos
C Lopez
A Natsios
G Radulescu
Haridarshan Patel
D Demuth
Andres J. Yarur
Show All
Source
Cite
Save
Citations (4)
P573 Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive ulcerative colitis patients: Results from the EVOLVE study
2019
Journal of Crohns & Colitis
Andres J. Yarur
G. Mantzaris
Mark S. Silverberg
M Walshe
P Zezos
D. Stein
M. Bassel
Trevor Lissoos
C Lopez
A Natsios
G Radulescu
H Patel
D Demuth
Brian Bressler
Show All
Source
Cite
Save
Citations (6)
P546 Vedolizumab outcomes in real-world bio-naive ulcerative colitis and Crohn’s disease patients (EVOLVE) in Canada: Interim results
2018
Journal of Crohns & Colitis
Brian Bressler
A J Greenup
M. Bassel
D. Stein
M Soni
G Radulescu
C Neish
Javaria Mona Khalid
D Demuth
Show All
Source
Cite
Save
Citations (1)
1